Article
Effective long-term control of cardiac events with beta-blockers in a family with a common LQT1 mutation.
Clinical genetics - 1 Mar 2004
Wedekind H, Schwarz M, Hauenschild S, Djonlagic H, Haverkamp W, Breithardt G, Wülfing T, Pongs O, Isbrandt D, Schulze-Bahr E
Abstract excerpt
The congenital long QT syndrome (LQTS) is characterized by a prolonged QT interval on the surface electrocardiogram and an increased risk of recurrent syncope and sudden cardiac death. Mutations in seven genes have been identified as the molecular basis of LQTS. beta-blockers are the treatment of choice to reduce cardiac symptoms. However, long-term follow-up of genotyped families with LQTS has been rarely...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
